This inventor holds 2 USPTO granted patents. Top assignee: Chiron Diagnostics Corporation. Active years: 1997-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1998
Title: The Innovative Contributions of David Kiaei
Introduction
David Kiaei is a notable inventor based in Stoughton, MA (US). He has made significant contributions to the field of assay methods, particularly in reducing non-specific binding in assays. With a total of 2 patents to his name, Kiaei's work has implications for various applications in diagnostics and research.
Latest Patents
Kiaei's latest patents focus on reagents for specific binding assays. One of his inventions describes a sensitive assay method that minimizes non-specific binding. This method involves detecting an analyte present in a sample through a specific binding reaction. In this process, either an analogue of the analyte or a specific binding partner is immobilized on a solid-phase. The specific binding reaction produces a detectable product that can be correlated to the amount of analyte in the sample. The assay employs an effective amount of a surfactant, which includes polyoxyethylene-alkylether and modified block copolymers, to reduce non-specific binding.
Career Highlights
David Kiaei is currently associated with Chiron Diagnostics Corporation, where he continues to innovate in the field of diagnostics. His work has been instrumental in advancing assay methodologies that enhance the accuracy and reliability of diagnostic tests.
Collaborations
Kiaei has collaborated with notable colleagues such as Uri Piran and Laurie A Livshin. These collaborations have likely contributed to the development and refinement of his patented technologies.
Conclusion
David Kiaei's contributions to assay methods and diagnostics underscore the importance of innovation in scientific research. His patents reflect a commitment to improving the accuracy of diagnostic assays, which can have a profound impact on healthcare and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile